Clinical Trials Browser

Phase 3 × Lymphohistiocytosis, Hemophagocytic × Dexamethasone × Clear all

NCT02912702 2016-09-23

L-DEP as an Initial Treatment for EBV-HLH

Phase 3 Unknown

Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic